C12N 2760/18732
Use of virus as therapeutic agent, other than vaccine
Official title: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N2760/18732 (Use of virus as therapeutic agent, other than vaccine) appears on 8 US grants and 10 published applications in this corpus.
Search patents in C12N- Granted patents
- 8
- Published applications
- 10
- Assignees
- 2
- Inventors
- 8
- Latest grant
- 27 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 1 | 0 |
| 2017 | 1 | 2 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 1 | 1 |
| 2021 | 0 | 1 |
| 2022 | 1 | 1 |
| 2023 | 2 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Oncolytic viruses for sensitizing tumor cells to killing by natural killer cells27 May 2025US 12,312,393 B2University of Central Florida Research Foundation, Inc.
- Oncolytic viruses for sensitizing tumor cells to killing by natural killer cells27 Jun 2023US 11,684,637 B2University of Central Florida Research Foundation, Inc.
- Parainfluenza virus 5 based vaccines3 Jan 2023US 11,542,527 B2University of Georgia Research Foundation, Inc.
- Multiple viral antigen COVID vaccine and therapeutic8 Nov 2022US 11,491,197 B2
- Parainfluenza virus 5 based vaccines25 Aug 2020US 10,752,916 B2University of Georgia Research Foundation, Inc.
- Novel oncolytic viruses for sensitizing tumor cells to killing by natural killer cells4 Jan 2024US 2024/0000842 A1University of Central Florida Research Foundation, Inc.
- Multiple viral antigen covid vaccine and therapeutic14 Apr 2022US 2022/0110987 A1
- Novel oncolytic viruses for sensitizing tumor cells to killing by natural killer cells20 May 2021US 2021/0145876 A1University of Central Florida Research Foundation, Inc.
- Parainfluenza virus 5 based vaccines3 Dec 2020US 2020/0377908 A1University of Georgia Research Foundation, Inc.
- Piv5 as an oncolytic agent19 Sep 2019US 2019/0284578 A1University of Georgia Research Foundation, Inc.
Most cited
By later US patents